NewslettersImmune Regulation NewsQuell Therapeutics Achieves Milestone for Type 1 Diabetes CAR-Treg Cell Therapy ProgramBy Jamie Kang - November 22, 2024036Quell Therapeutics, Ltd. announced that AstraZeneca has selected a candidate to progress in the Type 1 Diabetes Treg cell therapy program.[Quell Therapeutics, Ltd.]Press Release